Cardinal Health (NYSE: CAH) reported Q2 EPS of $1.52, $0.30 better than the analyst estimate of $1.22. Revenue for the quarter came in at $39.7 billion versus the consensus estimate of $39.43 billion.

GUIDANCE:

Cardinal Health sees FY2020 EPS of $5.20-$5.40, versus the consensus of $5.04.

• The company raises its fiscal year 2020 guidance range for non-GAAP diluted earnings per share attributable to Cardinal Health, Inc. to the range of $5.20 to $5.40 from the range of $4.85 to $5.10.

For earnings history and earnings-related data on Cardinal Health (CAH) click here.